A carregar...
Sodium-Glucose Cotransporter-2 Inhibitors in Nephrology Practice: A Narrative Review
PURPOSE OF THE REVIEW: Sodium-glucose cotransporter-2 inhibitors (SGLT2is) are recommended for eligible patients with type 2 diabetes for the secondary prevention of adverse cardiovascular and kidney disease outcomes. Patients with type 2 diabetes and albuminuric chronic kidney disease, a history of...
Na minha lista:
| Publicado no: | Can J Kidney Health Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7315675/ https://ncbi.nlm.nih.gov/pubmed/32637144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2054358120935701 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|